JP2010539490A - 多数の分析物の診断読み出し情報 - Google Patents

多数の分析物の診断読み出し情報 Download PDF

Info

Publication number
JP2010539490A
JP2010539490A JP2010525032A JP2010525032A JP2010539490A JP 2010539490 A JP2010539490 A JP 2010539490A JP 2010525032 A JP2010525032 A JP 2010525032A JP 2010525032 A JP2010525032 A JP 2010525032A JP 2010539490 A JP2010539490 A JP 2010539490A
Authority
JP
Japan
Prior art keywords
biomarkers
patient
diagnostic
protein
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010525032A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010539490A5 (enExample
Inventor
アンソニー シューバー,
Original Assignee
プレディクティブ バイオサイエンシーズ コーポレイション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by プレディクティブ バイオサイエンシーズ コーポレイション filed Critical プレディクティブ バイオサイエンシーズ コーポレイション
Publication of JP2010539490A publication Critical patent/JP2010539490A/ja
Publication of JP2010539490A5 publication Critical patent/JP2010539490A5/ja
Pending legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/60Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2010525032A 2007-09-14 2008-09-12 多数の分析物の診断読み出し情報 Pending JP2010539490A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US97250707P 2007-09-14 2007-09-14
US12/034,698 US20090075266A1 (en) 2007-09-14 2008-02-21 Multiple analyte diagnostic readout
PCT/US2008/076193 WO2009036288A1 (en) 2007-09-14 2008-09-12 Multiple analyte diagnostic readout

Publications (2)

Publication Number Publication Date
JP2010539490A true JP2010539490A (ja) 2010-12-16
JP2010539490A5 JP2010539490A5 (enExample) 2011-10-20

Family

ID=40452512

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010525032A Pending JP2010539490A (ja) 2007-09-14 2008-09-12 多数の分析物の診断読み出し情報

Country Status (6)

Country Link
US (1) US20090075266A1 (enExample)
EP (1) EP2198295A4 (enExample)
JP (1) JP2010539490A (enExample)
CN (1) CN101878426A (enExample)
CA (1) CA2698859A1 (enExample)
WO (1) WO2009036288A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015068760A (ja) * 2013-09-30 2015-04-13 シスメックス株式会社 好酸球性気道炎症に関する情報の取得方法およびそのような情報を取得するためのマーカー
JP2021528994A (ja) * 2018-06-27 2021-10-28 シーエス ジェネティックス リミテッドCs Genetics Limited 循環微粒子を分析するための方法

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090047694A1 (en) * 2007-08-17 2009-02-19 Shuber Anthony P Clinical Intervention Directed Diagnostic Methods
EP2527467A3 (en) * 2007-04-13 2013-03-20 Bristol-Myers Squibb Company Biomarkers and methods for determining sensitivity to vascular endothelial growth factor receptor-2 modulators
US20090029372A1 (en) * 2007-05-14 2009-01-29 Kobenhavns Universitet Adam12 as a biomarker for bladder cancer
US8431367B2 (en) 2007-09-14 2013-04-30 Predictive Biosciences Corporation Detection of nucleic acids and proteins
US20100267041A1 (en) * 2007-09-14 2010-10-21 Predictive Biosciences, Inc. Serial analysis of biomarkers for disease diagnosis
US7955822B2 (en) * 2007-09-14 2011-06-07 Predictive Biosciences Corp. Detection of nucleic acids and proteins
US20120053079A1 (en) * 2009-03-06 2012-03-01 University Of South Alabama Methods and compositions for the diagnosis, prognosis and treatment of cancer
JP5451552B2 (ja) * 2010-08-09 2014-03-26 オリンパス株式会社 顕微鏡システム、標本観察方法およびプログラム
EP2592421B1 (en) * 2011-11-14 2017-08-30 Universitätsklinikum Jena Diagnosis of sepsis and systemic inflammatory response syndrome
US20160130346A1 (en) * 2013-05-29 2016-05-12 Institut National De La Sante Et De La Recherche Medicale Kir3dl2 is a biomarker and a therapeutic target useful for respectively preventing and treating a subset of cutaneous and non-cutaneous peripheral t-cell lymphomas
AU2017225758B2 (en) * 2016-03-02 2023-03-16 Idexx Laboratories, Inc. Methods and compositions for the detection and diagnosis of renal disease and periodontal disease
WO2018187311A1 (en) * 2017-04-03 2018-10-11 Biodetego Llc Biomarkers and methods of using same
US20210325380A1 (en) * 2020-04-20 2021-10-21 EnLiSense, LLC Disease diagnostics using a multi-configurable sensing array
CN116930498B (zh) * 2023-08-29 2023-12-12 中国人民解放军军事科学院军事医学研究院 一种原发性肝细胞癌切除术后复发风险预测试剂盒及其应用

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002512814A (ja) * 1998-04-27 2002-05-08 エグザクト サイエンシーズ コーポレイション 核酸を検出するためのプライマ伸長法
JP2003235557A (ja) * 2002-02-14 2003-08-26 Univ Niigata 精神分裂病により発現量が変化する遺伝子を規定する核酸を解析する方法
WO2006089087A2 (en) * 2005-02-17 2006-08-24 Dana-Farber Cancer Institute, Inc. Compositions, kits and methods for identification, assessment, prevention and therapy of cancer
JP2006526140A (ja) * 2002-12-24 2006-11-16 バイオサイト インコーポレイテッド 鑑別診断のためのマーカーおよびその使用方法
JP2007523346A (ja) * 2004-02-19 2007-08-16 イェール ユニバーシティ プロテオーム技術を使用した癌タンパク質バイオマーカーの同定
JP2008529557A (ja) * 2005-02-16 2008-08-07 ワイス 白血病の診断、予後診断および処置選択のための方法およびシステム
JP2009501318A (ja) * 2005-06-24 2009-01-15 ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ アテローム動脈硬化性心血管疾患の診断およびモニタリングのための方法ならびに組成物
JP2010532480A (ja) * 2007-06-29 2010-10-07 アボット・ラボラトリーズ 肺癌に対する素因をスクリーニングするための方法およびマーカーの組み合わせ

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5324634A (en) * 1992-03-31 1994-06-28 The Research Foundation Of State University Of New York Diagnostic tests measuring gelatinase/inhibitor complexes for detection of aggressive and metastatic cancer
US20040219509A1 (en) * 2001-08-20 2004-11-04 Biosite, Inc. Diagnostic markers of stroke and cerebral injury and methods of use thereof
BRPI0609302A2 (pt) * 2005-04-15 2011-10-11 Becton Dickinson Co métodos para prever o desenvolvimento de sepse e para diagnosticar sepse em um indivìduo a ser testado, microarranjo, kit para prever o desenvolvimento de sepse em um indivìduo a ser testado, produto de programa de computador, computador, sistema de computador para determinar se um indivìduo é susceptìvel de desenvolver sepse, sinal digital embutido em uma onda portadora, e, interface gráfica de usuário para determinar se um indivìduo é susceptìvel de desenvolver sepse
US20090264306A1 (en) * 2005-10-27 2009-10-22 Curators Of The University Of Missouri Dna methylation biomarkers in lymphoid and hematopoietic malignancies
ES2606015T3 (es) * 2005-12-22 2017-03-17 Abbott Molecular Inc. Métodos y combinaciones de marcadores para la detección de la predisposición al cáncer de pulmón
US20070255113A1 (en) * 2006-05-01 2007-11-01 Grimes F R Methods and apparatus for identifying disease status using biomarkers
US20090047694A1 (en) * 2007-08-17 2009-02-19 Shuber Anthony P Clinical Intervention Directed Diagnostic Methods

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002512814A (ja) * 1998-04-27 2002-05-08 エグザクト サイエンシーズ コーポレイション 核酸を検出するためのプライマ伸長法
JP2003235557A (ja) * 2002-02-14 2003-08-26 Univ Niigata 精神分裂病により発現量が変化する遺伝子を規定する核酸を解析する方法
JP2006526140A (ja) * 2002-12-24 2006-11-16 バイオサイト インコーポレイテッド 鑑別診断のためのマーカーおよびその使用方法
JP2007523346A (ja) * 2004-02-19 2007-08-16 イェール ユニバーシティ プロテオーム技術を使用した癌タンパク質バイオマーカーの同定
JP2008529557A (ja) * 2005-02-16 2008-08-07 ワイス 白血病の診断、予後診断および処置選択のための方法およびシステム
WO2006089087A2 (en) * 2005-02-17 2006-08-24 Dana-Farber Cancer Institute, Inc. Compositions, kits and methods for identification, assessment, prevention and therapy of cancer
JP2009501318A (ja) * 2005-06-24 2009-01-15 ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ アテローム動脈硬化性心血管疾患の診断およびモニタリングのための方法ならびに組成物
JP2010532480A (ja) * 2007-06-29 2010-10-07 アボット・ラボラトリーズ 肺癌に対する素因をスクリーニングするための方法およびマーカーの組み合わせ

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
JPN6013020042; 近畿大学医学雑誌 Vol.31, No.2, Page.45-52, 2006 *
JPN6013020043; 日本医療薬学会年会講演要旨集 Vol.15th, Page.351 P-492, 2005 *
JPN6013020044; Biotherapy (Tokyo) Vol.17, No.5, Page.473-482, 2003 *
JPN6013020045; 整形・災害外科 Vol.46, No.2, Page.96-97, 2003 *
JPN6013020047; 'TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer' BREAST CANCER RESEARCH, 20070515 CURRENT SCIENCE, LONDON, GB - ISSN 1465-5411 Vol:9, Nr:3, Page(s):R30, 20070515 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015068760A (ja) * 2013-09-30 2015-04-13 シスメックス株式会社 好酸球性気道炎症に関する情報の取得方法およびそのような情報を取得するためのマーカー
JP2021528994A (ja) * 2018-06-27 2021-10-28 シーエス ジェネティックス リミテッドCs Genetics Limited 循環微粒子を分析するための方法

Also Published As

Publication number Publication date
WO2009036288A1 (en) 2009-03-19
CA2698859A1 (en) 2009-03-19
EP2198295A1 (en) 2010-06-23
EP2198295A4 (en) 2010-08-25
US20090075266A1 (en) 2009-03-19
CN101878426A (zh) 2010-11-03

Similar Documents

Publication Publication Date Title
JP2010539490A (ja) 多数の分析物の診断読み出し情報
US20090047694A1 (en) Clinical Intervention Directed Diagnostic Methods
CN113396332B (zh) 评价妊娠进展和早产流产以进行临床干预的方法及其应用
EP3230740B1 (en) Marker combinations for diagnosing infections and methods of use thereof
JP2004507740A (ja) 生化学マーカーを用いる繊維性疾患の診断方法
US9080206B2 (en) Detection of nucleic acids and proteins
JP6250600B2 (ja) 非小細胞肺癌バイオマーカーを検出する方法
US20120178100A1 (en) Serum Markers Predicting Clinical Response to Anti-TNF Alpha Antibodies in Patients with Psoriatic Arthritis
WO2015157557A1 (en) Methods of diagnosing pancreatic cancer and methods related thereto
ES2530209T3 (es) Métodos diagnósticos dirigidos a intervención clínica
CN113302495B (zh) 膀胱癌的检测
US20220283157A1 (en) Multiplexed assay kits for evaluation of systemic lupus erythematosus
US20160018413A1 (en) Methods of Prognosing Preeclampsia
US20230375554A1 (en) Identification and characterization of ovarian cancer specific biomarkers in vaginal secretions
CN119630966A (zh) 用于对膀胱癌进行风险分层和管理的方法和系统
US20250224406A1 (en) Markers for progression of inflammatory liver disease
HK1138376B (en) Clinical intervention directed diagnostic methods
CN121049516A (zh) 一种用于肺鳞癌诊断的联合诊断标志物的应用
Rhea 1. Home Cancer Biomarkers: Surviving the journey from bench to bedside March 1, 2011
CN105452484A (zh) 新颖的生物标志物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110830

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20110830

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120403

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20120403

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20120718

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120724

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130425

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20130724

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20130731

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20131203